ASBMT News  by unknown
The 2008 BMT Tandem Meetings
will convene February 13–17 at the
Manchester Grand Hyatt Hotel in
San Diego, California.
Parallel conferences to be held in
conjunction with the main scientific
meeting will include:
 Clinical Research Professionals—
February 12–14
 BMT Administrative Directors—
February 13–14
 Pediatric BMT—February 14
 BMT Pharmacists—February 15–
17
 Transplant Nursing—February
15–17
In addition to the program high-
lights listed below, 78 speaker presen-
tations will be based on submitted
abstracts.
WEDNESDAY—FEBRUARY 13
7:15 a.m.—Breakfast Sym-
posium
8:30 a.m.
Graft versus Leukemia
 GVL—Breaking theBlack Box Open
Stanley Riddell, MD
 GVL Against Murine Chronic
Phase and Blast Crisis CML
Warren D. Shlomchik, MD
 Engineering GVL Through T-Cell
Gene Transfer
Michael Jensen, MD
10:30 a.m.
Summary of BMT State of the
Science Symposium
James L.M. Ferrara, MD, MS;
Daniel Weisdorf, MD; Frederick
Appelbaum, MD; and Dennis
Confer, MD
10:30 a.m.
Amyloidosis: The New, the
Old and the Role of High-
Dose Chemotherapy with
Stem Cell Support
 Diagnosis and Prognosis of Pa-
tients with AL Amyloidosis
Angela Dispenzieri, MD
 Transplant Options for AL Amyloid-
osis
Raymond L. Comenzo, MD
 Nontransplant Options for AL
Amyloidosis
Giampaolo Merlini, MD
10:30 a.m.
Cancer Stem Cells
 Development of Cancer Stem Cells
in AML
Scott Armstrong, MD, PhD
 Molecular Dissection of Blast Crisis
Leukemia Stem Cells
Catriona Jamieson, MD, PhD
 Cancer Stem Cells in Lymphoid
Malignancies
Richard J. Jones, MD
12:15 p.m.—Luncheon
Symposium
4:30 p.m.
Oral Abstracts
6:35 p.m.
Mortimer M. Bortin Lecture
 Allografting for CML—What Have
We Learned and Where Do We
Stand?
John M. Goldman, DM
7:05 p.m.
Welcome Reception
THURSDAY—FEBRUARY 14
7:15 a.m.—Breakfast
Symposium
8:30 a.m.
Stem Cell Interactions and
Kinetics
 Stem Cells at Home and Abroad
David Scadden, MD
 Mesenchymal Stem Cells and
Immune Function
Willem Fibbe, MD, PhD
 Quantitating Stem Cells and Their
Divisive Capacity
Janis Abkowitz, MD
10:30 a.m.
Memory T Cells
 T cells in GVHD
Nelson Chao, MD
 Memory T Cells in GVHD
Warren D. Shlomchik, MD
 Functional Differences of Memory
T Cells
Benny J. Chen, MD
10:30 a.m.
Endothelial Biology and
Transplant-Related Compli-
cations
 Contribution of Endothelial Activa-
tion and Injury to End-Organ
Toxicity Following Allogeneic
Hematopoietic Stem Cell Trans-
plantation
Kenneth R. Cooke, MD
 Endothelial Cells: Potential Novel
Targets for GVHD
Anne Janin, MD, PhD
 Overview, Diagnosis andTreatment
of Thrombotic Microangiopathy
after Allogeneic Hematopoietic
Stem Cell Transplantation
Vincent T. Ho, MD
10:30 a.m.
CIBMTR/EBMT Key Studies
Sergio Giralt, MD, and Dietger
Niederweiser, MD
10:30 a.m.
Immunotherapy for Pediat-
ric Cancer
Laurence J.N. Cooper, MD, Chair
 Cell Therapies in High-Risk Pediat-
ric Malignancies
Stephen A. Grupp, MD, PhD
 Incorporation of Therapeutic
Monoclonal Antibodies into Child-
hood Cancer Trials
Paul M. Sondel, MD, PhD
 Harnessing the (Natural) Killer dur-
ing Transplantation
Michael R. Verneris, MD
12:15 p.m.—Luncheon Sym-
posium
1:30 p.m.
Alternative Allogeneic Do-
nor Sources for Transplanta-
tion for Childhood Diseases
Mitchell S. Cairo, MD, Chair
 Unrelated Donor Transplants for
Pediatric Nonmalignant Disease,
including Hemoglobinopathies
Vanderson Rocha, MD1528
2008 BBMT Tandem Meetings 1529 Haploidentical Transplants for
Childhood Hematologic Malig-
nancies
Gregory A. Hale, MD
 The Influence of Cell Dose and
HLA Match on Unrelated Cord
Blood Transplantation
John E. Wagner, MD
1:30 p.m.
Pediatric Perspectives on
Immune Reconstitution and
Vaccination
 Revaccination after Allogeneic
Stem Cell Transplantation
Trudy M. Small, MD
 Improved Immune Reconstitution
and Low Mortality after Haploi-
dentical Transplantation Using
Reduced-Intensity Conditioning
and CD3/CD19 Depletion
Rupert Handgretinger, MD, PhD
 Immune Reconstitution after Un-
related Cord Blood Transplan-
tation: The Expected and the
Unique
Paul Szabolcs, MD
3:00 p.m.
Hematopoietic Stem Cell
Transplantation for Severe
Combined Immunodefi-
ciency Diseases
 Issues of Transplantation for SCID
Morton J. Cowan, MD
 Late Immunological and Clinical
Outcome for a Large Cohort of
Transplanted SCID Patients
Be´ne´dicte Neven, MD
 Newborn Screening for SCID
Jennifer M. Puck, MD
 How Do We Organize a Clinical
Trial for SCID? (Panel Discus-
sion)
Trudy M. Small, MD; Luigi D. Nota-
rangelo, MD; Naynesh Kamani,
MD; Neena Kapoor, MD; and Alex-
andra H. Filipovich, MD
3:00 p.m.
Late Effects of Transplanta-
tion in Children and Adoles-
cents
 Oral and Dental Late Effects after
Pediatric Stem Cell Transplantation
Go¨ran Dahllo¨f, DDS, PhD
 The Kidney after Hematopoietic
Cell Transplantation
Sangeeta Hingorani, MD, MPH
 Evaluation for Late Effects after
Pediatric Hematopoietic Cell Trans-
plantation
Jean E. Sanders, MD
4:30 p.m.
Oral Abstracts
6:00 p.m.
Poster Session I
7:30 p.m.—Dinner Sympo-
sium
FRIDAY—FEBRUARY 15
7:15 a.m.—Breakfast Sym-
posium
8:30 a.m.
Tolerance Induction for He-
matopoietic and Solid Organ
Graft Acceptance
 Costimulation Blockade and Chi-
merism Strategies for Organ Trans-
plant Tolerance
Christian P. Larsen, MD, PhD
 Embryonic Pig Tissues as a Source
for Organ Transplantation
Yair Reisner, PhD
 Regulation of Allogeneic T Cell Re-
sponses in BMT
Bruce R. Blazar, MD
10:30 a.m.
Clinical Strategies to En-
hance Posttransplant Im-
mune Reconstitution
 Interleukin-7 and Keratinocyte
Growth Factor for Posttransplant
T Cell Reconstitution
Marcel R.M.vandenBrink,MD,PhD
 Notch Signaling in Hematopoiesis:
Implications for Improving Stem
Cell Transplantation
Irwin Bernstein, MD
 Enhancement of Immune Recon-
stitution Following Myeloablative
Chemotherapy by Inhibition of
Sex Steroid Production
Richard Boyd, PhD
10:30 a.m.
Controversies in Lymphoma
Therapy
 Diffuse Large Cell Lymphoma:
Gene Expression Profiling and
Prognosis
Izidore S. Lossos, MD
 Hematopoietic Cell Transplanta-
tion for T Cell Non-Hodgkin Lym-
phoma: Does it Work?
Ginna G. Laport, MD
 Mantle Cell Lymphoma in First Re-
mission: What Next?
Peter Dreger, MD, PhD
10:30 a.m.
Selecting Donors and Cord
Blood Units: Evidence-Based
Decisions (NMDP Session)
 Selecting Optimal Adults Donors
Stephanie Lee, MD, MPH
 Selecting Optimal Cord Blood
Units
Naynesh Kamani, MD
 Making the Decision—Donor Se-
lection Case Studies
Dennis Confer, MD
12:15 p.m.—Luncheon Sym-
posium
4:30 p.m.
Best Abstracts Session
6:15 p.m.
E. Donnall Thomas Lecture
 The Genetics of Hematopoietic
Cell Transplantation
John A. Hansen, MD
7:15 p.m.—Dinner Sympo-
sium
SATURDAY—FEBRUARY 16
7:15 a.m.—Breakfast Sym-
posium
8:30 a.m.
Human Polymorphism and
the Outcome of Therapy
 Pharmacogenetics and the Out-
come of Therapy for Leukemia
Stella M. Davies, MD, PhD
 Cytokine Gene Polymorphism and
Outcome of Hematopoietic Trans-
plantation
Anne Dickinson, PhD
 KIR gene Polymorphism and Ther-
apy of Leukemia
Jeffrey Miller, MD
10:30 a.m.
Oral Abstracts
12:15 p.m.—Luncheon Sym-
posium
1:30 p.m.
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1:30 p.m.
Mouse Models of BMT
 CTL Priming and Generation dur-
ing GVL
Geoff Hill, MD
 Imaging Graft-versus-Host Reac-
tions in Living Animals
Robert Negrin, MD
 Mouse Models of GVL: Promise
and Pitfalls
Pavan Reddy, MD
4:30 p.m.
T Cell Therapy
 Adoptive Transfer of Virus-Specific
T Cells
Helen Heslop, MD
 Treatment of Hematological Malig-
nancies with Alloreactive T Cells
J.H. Frederik Falkenburg,MD, PhD
 Antitumor Therapy with T Cells
Recognizing Tumor-Associated
Self-Antigens
John Barrett, MD
4:30 p.m.
Chronic GVHD: How Can We
Release Prometheus?
Paul J. Martin, MD
 Immunobiology of Chronic GVHD:
Insights from Animal Models
Takanori Teshima, MD
 Pathophysiology of Fibrosis
Thomas A. Wynn, PhD
 Treg for Treatment of Chronic
GVHD: Promise or Peril?
Robert J. Soiffer, MD
4:30 p.m.
Stem Cells and Regenerative
Medicine
 Adult Bone Marrow and Cord
Blood-Derived Very Small Embry-
onic-Like Stem Cells—Our Key to
Longevity
Mariusz Ratajczak, MD, PhD
 The Homeostatic Pressure Exerted
by Stem Cells in Degenerative or
Injured CNS Environments
Evan Snyder, PhD
 The Role of Adult Stem Cells from
Bone Marrow and Cord Blood in
Regenerative Medicine
Jan A. Nolta, PhD
6:00 p.m.
Poster Session II
7:30 p.m.
ASBMT President’s Dinner
SUNDAY—FEBRUARY 17
7:15 a.m.—Breakfast Sym-
posium
8:30 a.m.
Transplants for Acute Leuke-
mia
 Pediatric Acute Leukemia
Stella M. Davies, MD, PhD
 Adult Acute Lymphoblastic Leuke-
mia
Jacob Rowe, MD
 Adult Acute Myeloid Leukemia
Frederick R. Appelbaum, MD
10:30 a.m.
Oral Abstracts
12:15 p.m.
The Aging Stem Cell and its
Niche: Implications for Stem
Cell Function, Transplanta-
tion and Transformation
 Aging Stem Cells: Role of Genetics
on Function
Gary Van Zant, PhD
 Cell Intrinsic and Environmental Al-
terations Limiting Stem Cell Func-
tion During Aging
Lenhard Rudolph, MD
 Declining Cellular Fitness with Age
Promotes the Adaptive Evolution
of Cancer
James DeGregori, PhD
12:15 p.m.
Graft Failure after Hemato-
poietic Stem Cell Transplan-
tation
 Graft Failure—An Increasing Prob-
lem after Hematopoietic Stem Cell
Transplantation
Olle Ringde´n, MD, PhD
 Overcoming Host-versus-Graft Re-
actions: Preclinical Studies and
Clinical Translation
Rainer F. Storb, MD
 Antibody-Mediated Graft Failure
after Allogeneic Hematopoietic
Stem Cell Transplantation
Jonas Mattsson, MD
1:45 p.m.
Adjourn
